A. Martiniuc, Ana Stănilă, D. Tabacelia, Radu Poenaru, Stefana Dumitras, Florina A. Nitu, R. Dumitru, M. Florescu, R. Grigorescu, C. Rosianu, L. Popa, Adelina Birceanu, D. Chiriţă, C. Stroescu
{"title":"“恶性疾病患者感染严重急性呼吸系统综合征冠状病毒2型的临床后果”","authors":"A. Martiniuc, Ana Stănilă, D. Tabacelia, Radu Poenaru, Stefana Dumitras, Florina A. Nitu, R. Dumitru, M. Florescu, R. Grigorescu, C. Rosianu, L. Popa, Adelina Birceanu, D. Chiriţă, C. Stroescu","doi":"10.31688/abmu.2022.57.1.12","DOIUrl":null,"url":null,"abstract":"Introduction. The coronavirus disease 2019 (COVID-19) pandemic has constrained healthcare units to reorganize hospital departments, substantially reducing their capacity to perform oncology-related surgeries. Despite the efforts to reduce the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during hospitalization, COVID-19 has complicated the recovery of many surgical patients. Our objective was to assess the impact of SARS-CoV-2 infection on the postoperative evolution of patients with pancreatic surgery. Cases presentation. We present four patients with pancreaticoduodenectomy for malignant disease, operated in our hepato-biliary-pancreatic surgery department, who presented COVID-19 in the postoperative period, despite initial negative screening. 10% of patients who had pancreaticoduodenectomies were subsequently detected with minimal, moderate to severe forms of COVID-19 in the postoperative period, which led to an extension of the hospitalization period, in some cases, by up to five weeks. Conclusions. The side effects of COVID-19 pandemic are yet to have reached their limits. Pancreaticoduodenectomy is a complex surgery with high morbidity rates, but during the COVID-19 pandemics it has become more challenging.","PeriodicalId":40057,"journal":{"name":"Archives of the Balkan Medical Union","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"\\\"THE CLINICAL CONSEQUENCES OF SARS-CoV-2 INFECTION IN PATIENTS WITH PANCREATICODUODENECTOMY FOR MALIGNANT DISEASE\\\"\",\"authors\":\"A. Martiniuc, Ana Stănilă, D. Tabacelia, Radu Poenaru, Stefana Dumitras, Florina A. Nitu, R. Dumitru, M. Florescu, R. Grigorescu, C. Rosianu, L. Popa, Adelina Birceanu, D. Chiriţă, C. Stroescu\",\"doi\":\"10.31688/abmu.2022.57.1.12\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction. The coronavirus disease 2019 (COVID-19) pandemic has constrained healthcare units to reorganize hospital departments, substantially reducing their capacity to perform oncology-related surgeries. Despite the efforts to reduce the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during hospitalization, COVID-19 has complicated the recovery of many surgical patients. Our objective was to assess the impact of SARS-CoV-2 infection on the postoperative evolution of patients with pancreatic surgery. Cases presentation. We present four patients with pancreaticoduodenectomy for malignant disease, operated in our hepato-biliary-pancreatic surgery department, who presented COVID-19 in the postoperative period, despite initial negative screening. 10% of patients who had pancreaticoduodenectomies were subsequently detected with minimal, moderate to severe forms of COVID-19 in the postoperative period, which led to an extension of the hospitalization period, in some cases, by up to five weeks. Conclusions. The side effects of COVID-19 pandemic are yet to have reached their limits. Pancreaticoduodenectomy is a complex surgery with high morbidity rates, but during the COVID-19 pandemics it has become more challenging.\",\"PeriodicalId\":40057,\"journal\":{\"name\":\"Archives of the Balkan Medical Union\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of the Balkan Medical Union\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31688/abmu.2022.57.1.12\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of the Balkan Medical Union","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31688/abmu.2022.57.1.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
"THE CLINICAL CONSEQUENCES OF SARS-CoV-2 INFECTION IN PATIENTS WITH PANCREATICODUODENECTOMY FOR MALIGNANT DISEASE"
Introduction. The coronavirus disease 2019 (COVID-19) pandemic has constrained healthcare units to reorganize hospital departments, substantially reducing their capacity to perform oncology-related surgeries. Despite the efforts to reduce the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during hospitalization, COVID-19 has complicated the recovery of many surgical patients. Our objective was to assess the impact of SARS-CoV-2 infection on the postoperative evolution of patients with pancreatic surgery. Cases presentation. We present four patients with pancreaticoduodenectomy for malignant disease, operated in our hepato-biliary-pancreatic surgery department, who presented COVID-19 in the postoperative period, despite initial negative screening. 10% of patients who had pancreaticoduodenectomies were subsequently detected with minimal, moderate to severe forms of COVID-19 in the postoperative period, which led to an extension of the hospitalization period, in some cases, by up to five weeks. Conclusions. The side effects of COVID-19 pandemic are yet to have reached their limits. Pancreaticoduodenectomy is a complex surgery with high morbidity rates, but during the COVID-19 pandemics it has become more challenging.